Below you'll find a list of all posts that have been categorized as “Life sciences”
Vaccine supply chains are fast changing, complex and vitally important to society, and nowhere is this more evident than with COVID-19. While a great deal of attention has been given to streamlining supply chains – and ensuring vaccines reach healthcare providers and their patients around the world – one of the most critical components is also the most overlooked: the …
The medical device market has been growing at a compound annual growth rate of five percent and with an aging population, the COVID-19 pandemic, and the prevalence of chronic disease, it’s showing no signs of slowing. It’s a challenging time for medical device manufacturers. They are forced to balance demands for quality and compliance with operational efficiency – at times …
There’s no way around it. Regulators require that life sciences companies validate their solutions. At the same time, manufacturers are under pressure to streamline operations, reduce costs and increase efficiency to compete in a challenging market environment. In many ways, it might seem like a near-impossible task: spending the time and resources necessary to achieve and maintain compliance, while at …
To find out more about the benefits this recent acquisition provides to customers in the medical device, clinical trials, and pharmaceutical labeling space make sure you register for our upcoming webinar on January 25th at 10AM ET/4PM CET. We’re pleased to today announce that PRISYM ID, a leading provider of regulated content and label management solutions with a focus on …
As companies strive to improve their time to market, a common challenge is finding an efficient way to manage a plethora of label variations. Every product has different labeling needs, depending on industry, customer, etc., and these needs can change rapidly and unexpectedly at any given time. That means that it is crucial not just to stay on top of …
Imagine investing fifteen years or more in developing a promising new drug, only to have a simple labeling error derail your launch plans, or – even worse – result in a product being quarantined or recalled from the market. Unfortunately, this is not at all uncommon. FDA drug recalls are on the rise, increasing 65% over the last decade(Source: GS1), …
Digital transformation has taken the world by storm. An increasing number of companies are adopting cloud-first strategies with pandemic-driven remote work accelerating this transition. However, this step toward modernization comes with some challenges for regulated companies. The myriad of labeling guidelines, along with the requirements and regulations that life sciences companies face can be overwhelming. What’s more, they’re constantly changing …
The medical device industry is poised for growth in the coming years. This presents opportunities for many, but also immense challenges and greater strain on the supply chain. And considering that the medical device industry is highly regulated, these companies also have to pay special attention to varying requirements across borders, lengthy approval processes and non-compliance penalties – all of …
Mergers and acquisitions are all too common for pharmaceutical manufacturers. While the combination of two companies has its benefits, it doesn’t come without growing pains and challenges. Take for example, labeling. A merger can result in decentralized labeling processes with inherited home-grown systems and a new array of third-party suppliers, contract manufacturers, re-packagers and re-labelers. It can also lead to …
The EU MDR one-year delay gives you the opportunity to take a more measured, strategic approach to compliance. However, it’s important to use the time wisely. In this blog, we highlight five steps that will help you on the road to UDI compliance. We’ll also talk about how to review your existing labeling processes and ensure you’re using the best …
